» Articles » PMID: 37626650

Exploring the Pathogenesis and Mechanism-Targeted Treatments of Rosacea: Previous Understanding and Updates

Overview
Journal Biomedicines
Date 2023 Aug 26
PMID 37626650
Authors
Affiliations
Soon will be listed here.
Abstract

Rosacea is a chronic inflammatory skin disease characterized by recurrent erythema, flushing, telangiectasia, papules, pustules, and phymatous changes in the central area of the face. Patients with this condition often experience a significant negative impact on their quality of life, self-esteem, and overall well-being. Despite its prevalence, the pathogenesis of rosacea is not yet fully understood. Recent research advances are reshaping our understanding of the underlying mechanisms of rosacea, and treatment options based on the pathophysiological perspective hold promise to improve patient outcomes and reduce incidence. In this comprehensive review, we investigate the pathogenesis of rosacea in depth, with a focus on emerging and novel mechanisms, and provide an up-to-date overview of therapeutic strategies that target the diverse pathogenic mechanisms of rosacea. Lastly, we discuss potential future research directions aimed at enhancing our understanding of the condition and developing effective treatments.

Citing Articles

DNAJB2 Attenuates Rosacea Skin Inflammation and Angiogenesis by Inhibiting the Endoplasmic Reticulum Stress-mediated TLR2/Myd88/NF-κB pathway.

Qing Y, Wu J, Xu B, Xu Z, Ye S, Wang Y Inflammation. 2025; .

PMID: 40035989 DOI: 10.1007/s10753-025-02278-5.


30% Supramolecular Salicylic Acid Improved Symptoms and Skin Barrier in Papulopustular Rosacea.

Wang Z, Wu Y, Varkani F, Su X, Yang Z, Gao X J Cosmet Dermatol. 2025; 24(2):e70046.

PMID: 39968706 PMC: 11836920. DOI: 10.1111/jocd.70046.


Harnessing Ultrasonic Technologies to Treat Skin Infections.

Hulme J Molecules. 2025; 30(3).

PMID: 39942617 PMC: 11819699. DOI: 10.3390/molecules30030512.


Serum Biomarkers IL-6 and HIF-1α in Rosacea: Assessing Their Significance in Disease Pathogenesis and Telangiectasia Formation.

Tas-Aygar G, Cevirgen Cemil B, Aydin F, Buran V, Kartal S Dermatol Pract Concept. 2024; 14(4).

PMID: 39652912 PMC: 11620185. DOI: 10.5826/dpc.1404a267.


Azelaic Acid: Mechanisms of Action and Clinical Applications.

Feng X, Shang J, Gu Z, Gong J, Chen Y, Liu Y Clin Cosmet Investig Dermatol. 2024; 17:2359-2371.

PMID: 39464747 PMC: 11512533. DOI: 10.2147/CCID.S485237.


References
1.
Son M, Park J, Oh S, Choi J, Shim M, Kang D . Radiofrequency irradiation attenuates angiogenesis and inflammation in UVB-induced rosacea in mouse skin. Exp Dermatol. 2020; 29(7):659-666. DOI: 10.1111/exd.14115. View

2.
Li J, Yuan X, Tang Y, Wang B, Deng Z, Huang Y . Hydroxychloroquine is a novel therapeutic approach for rosacea. Int Immunopharmacol. 2020; 79:106178. DOI: 10.1016/j.intimp.2019.106178. View

3.
Park K, Ikushiro H, Seo H, Shin K, Kim Y, Kim J . ER stress stimulates production of the key antimicrobial peptide, cathelicidin, by forming a previously unidentified intracellular S1P signaling complex. Proc Natl Acad Sci U S A. 2016; 113(10):E1334-42. PMC: 4791017. DOI: 10.1073/pnas.1504555113. View

4.
Denda M, Kitamura K, Elias P, Feingold K . trans-4-(Aminomethyl)cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. J Invest Dermatol. 1997; 109(1):84-90. DOI: 10.1111/1523-1747.ep12276640. View

5.
Nikkari T . Comparative chemistry of sebum. J Invest Dermatol. 1974; 62(3):257-67. DOI: 10.1111/1523-1747.ep12676800. View